MENU
+Compare
BRSYF
Stock ticker: OTC
AS OF
Aug 12 closing price
Price
$5.49
Change
+$2.09 (+61.47%)
Capitalization
292.74M

BRSYF stock forecast, quote, news & analysis

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders... Show more

BRSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for BRSYF with price predictions
Sep 04, 2025

BRSYF's Stochastic Oscillator sits in oversold zone for 5 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 16 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Moving Average Convergence Divergence Histogram (MACD) for BRSYF turned negative on September 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 15 similar instances when the indicator turned negative. In of the 15 cases the stock turned lower in the days that followed. This puts the odds of success at .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BRSYF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.046) is normal, around the industry mean (59.958). P/E Ratio (39.214) is within average values for comparable stocks, (37.886). BRSYF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.671). BRSYF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (4.690) is also within normal values, averaging (80.383).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Boston Scientific Corp (NYSE:BSX), Medtronic plc (NYSE:MDT), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.63B. The market cap for tickers in the group ranges from 1.86K to 231.15B. ABT holds the highest valuation in this group at 231.15B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was -0%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 25%. VMTHF experienced the highest price growth at 107%, while AEMD experienced the biggest fall at -64%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was 99%. For the same stocks of the Industry, the average monthly volume growth was 86% and the average quarterly volume growth was 41%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 77
Price Growth Rating: 62
SMR Rating: 88
Profit Risk Rating: 92
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
BRSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
19 Hartum Street
Phone
+972 25824030
Employees
106
Web
https://www.brainsway.com